Comparison
3 Hydroxyisobutyric Aciduria C0342737 vs 17q11 2 Microduplication Syndrome C3495679
Clinical comparison between 3 Hydroxyisobutyric Aciduria and 17q11 2 Microduplication Syndrome for differential diagnosis and treatment planning.
3 Hydroxyisobutyric Aciduria C0342737
A rare metabolic condition where the body cannot properly break down certain amino acids. It can cause developmental delay, intellectual disability, and metabolic problems. Management involves dietary modifications and supportive care.
17q11 2 Microduplication Syndrome C3495679
A genetic disorder caused by duplication of a segment on chromosome 17. Individuals may have developmental delays, behavioral concerns, and physical features. Treatment focuses on early intervention.
6 comparison axes
Onset
3 Hydroxyisobutyric Aciduria C0342737
0-5
17q11 2 Microduplication Syndrome C3495679
0-null
Onset patterns differ
Severity
3 Hydroxyisobutyric Aciduria C0342737
severe
17q11 2 Microduplication Syndrome C3495679
moderate
Different severity levels
Chronic
3 Hydroxyisobutyric Aciduria C0342737
Chronic
17q11 2 Microduplication Syndrome C3495679
Chronic
Differing course
Communicable
3 Hydroxyisobutyric Aciduria C0342737
No
17q11 2 Microduplication Syndrome C3495679
No
Different transmission
Body System
3 Hydroxyisobutyric Aciduria C0342737
metabolic
17q11 2 Microduplication Syndrome C3495679
congenital
Same/different system
Category
3 Hydroxyisobutyric Aciduria C0342737
metabolic
17q11 2 Microduplication Syndrome C3495679
genetic
Different category
Bottom line
3-hydroxyisobutyric-aciduria-C0342737 and 17q11-2-microduplication-syndrome-C3495679 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 3 Hydroxyisobutyric Aciduria C0342737 | 17q11 2 Microduplication Syndrome C3495679 | Discriminating power |
|---|---|---|---|
| Developmental delay | May accompany intellectual disability and metabolic problems. | May occur with behavioral concerns and physical features. | Moderate |
| Metabolic illness | Possible because amino-acid breakdown is impaired. | Not described as a primary metabolic disorder. | High |
| Behavioral or physical features | A specific pattern is not established in the source. | Behavioral concerns and physical features may be present. | Moderate |
When to favor each condition
Choose 3 Hydroxyisobutyric Aciduria C0342737 when
Early childhood illness suggests a metabolic disorder
The source links this condition to impaired amino-acid breakdown.
Moderate
Organic-acid testing suggests 3-hydroxyisobutyric aciduria
The finding supports specialist review but is not a diagnosis alone.
High
Dietary and metabolic support is being considered
Management is described as dietary modification and supportive care.
Moderate
Choose 17q11 2 Microduplication Syndrome C3495679 when
Delay occurs with behavioral and physical features
This pattern matches the supplied syndrome description.
Moderate
Testing identifies a 17q11.2 duplication
The duplication supports the named condition after clinical correlation.
High
Early developmental intervention is the main need
The source emphasizes early intervention rather than metabolic treatment.
Moderate
How key tests differ
| Test | 3 Hydroxyisobutyric Aciduria C0342737 | 17q11 2 Microduplication Syndrome C3495679 | Interpretation |
|---|---|---|---|
| Urine organic-acid analysis | May suggest abnormal 3-hydroxyisobutyric acid; no cutoff is established here. | Not expected to define the duplication syndrome. | An abnormal metabolite is a clue, not a standalone diagnosis. |
| Chromosomal microarray | Not the primary test for this metabolic condition. | May detect duplication at 17q11.2. | Genetic findings require laboratory and clinician correlation. |
| Metabolic assessment during illness | May show metabolic disturbance; exact values are not established. | No characteristic metabolic abnormality is established here. | Distinguish an abnormal test result from either diagnosis. |
Prognosis comparison
3 Hydroxyisobutyric Aciduria C0342737
- Outcome
- Outcome is variable and unquantified; severe impact is possible.
- Factors
- Metabolic stability, developmental support, and complications may influence course.
17q11 2 Microduplication Syndrome C3495679
- Outcome
- Described as moderate, but individual outcome is not established.
- Factors
- Development, behavior, associated features, and early intervention may matter.
Time frame: Childhood onset with a chronic course; no exact timeline is established.
Etiology, severity, comorbidities, and access to supportive care.
Complications comparison
| Complication | Presentation |
|---|---|
| Intellectual or developmental impairment | Intellectual disability is described as possible. Developmental delay is possible; cognitive outcome is not established. Both require individualized developmental assessment. |
| Acute metabolic decompensation | A possible concern in this metabolic disorder. Not described as a typical feature. Emergency metabolic planning depends on clinical indication. |
| Behavioral difficulties | Not specifically established by the source. Behavioral concerns are described. Support should follow assessment rather than assumptions. |
Patient education highlights
- HighSpecialist interpretation
These rare conditions are not interchangeable; a clinician should interpret all results.
- HighUrgent symptoms
Seek urgent care for lethargy, poor feeding, vomiting, or sudden regression when metabolic illness is suspected.
- MediumSupport services
Early intervention, educational support, and genetics or metabolic counseling may be helpful.